SCSvetlana N. Chebysheva

Svetlana N. Chebysheva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Svetlana N. Chebysheva has a total of 123 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Inflammatory bowel disease and allergy in children: Investigating the relationship. A retrospective study

    by Angelina V. Polyanskaya, Полянская Ангелина Валерьевна, Svetlana N. Chebysheva, Чебышева Светлана Николаевна, Marina D. Shakhnazarova, Шахназарова Марина Далгатовна, Olga G. Sukhovjova, Суховьева Ольга Геннадиевна, Irina M. Korsunskaya, Корсунская Ирина Марковна, et al.

    Background. Inflammatory bowel disease (IBD) and allergic diseases (ADs) share some pathogenetic mechanisms. The intersection of IBD and ADs is increasingly discussed within the scientific community. However, pediatric data on the relationship between IBD and allergy remain limited, particularly in the Russian literature, warranting this study. Aim. To determine the prevalence and characteristics of allergic disorders in children diagnosed with IBD, and to compare these findings with a control group of children with juvenile idiopathic arthritis (JIA). Materials and methods. The main group comprised 54 children diagnosed with IBD, with a mean age of 13.2±3.8 years, including 32 patients (59.3%) diagnosed with Crohn's disease and 22 patients (40.7%) diagnosed with ulcerative colitis. The comparison group included 34 patients with JIA, with a mean age of 11.9±4.3 years. All participants were observed at the Clinic of Children's Diseases of the Sechenov Center for Motherhood and Childhood. Diagnoses were confirmed in accordance with the current clinical guidelines issued by the Ministry of Health of Russia. The study evaluated the family history of ADs, the frequency of adverse perinatal events, feeding practices, and the frequency and types of allergic manifestations (including asthma, atopic dermatitis, allergic rhinitis, and food and drug allergies) in each group with a comparative analysis of the collected data. Statistical analyses were performed using Stata software, employing the Shapiro–Wilk test, Student's t-test, Mann–Whitney test, Pearson's χ² test, Fisher's exact test, and logistic regression to calculate odds ratios and 95% confidence intervals. Differences were considered statistically significant at p 0.05. Results. Among the children diagnosed with IBD, 59.3% reported allergic disorders, with 25.9% exhibiting two or more allergies. The most prevalent allergies included atopic dermatitis (18.5%) and food allergies (27.8%), with drug allergies observed in 14.8% of children in this group. Perinatal complications were noted in 44.4% of these patients. 47.4% of patients had been breastfed for over six months, and a family history of ADs was documented in 25.9% of the children. In contrast, allergic manifestations were reported in 38.2% of the JIA group; the most common manifestations included atopic dermatitis (20.6%) and food or drug allergies (11.8% each), with asthma and allergic rhinitis being less common (2.9% each). A complicated early medical history was recorded in 50.0% of JIA patients, with 29.4% having been breastfed for more than six months, and 14.7% showing a family history of ADs. Conclusion. The prevalence of ADs in children diagnosed with IBD is significantly higher than in the general population. Although the prevalence of allergies in children with JIA is also higher compared to the overall population data, the difference is not statistically significant. It remains lower than that observed in children with IBD (Fisher's exact test p=0.079). However, the probability of developing allergies in IBD patients was approximately 2.9 times greater than that of JIA patients, with the most pronounced trend in food allergy. The findings of this study suggest a probable association between IBD and the prevalence of allergic disorders.

  • Open Access

    Changes in cytokine expression in pediatric patients with juvenile arthritides and Crohnʼs disease

    by A. V. Polyanskaya, A. G. Soboleva, A. V. Mezentsev, V. V. Sobolev, S. N. Chebysheva, N. A. Geppe, I. M. Korsunskaya

    Introduction . Juvenile idiopathic arthritis, juvenile psoriatic arthritis, and Crohn's disease are progressive immune-mediated disorders carrying a high risk of early disability. Aim. To analyze changes in serum cytokines to identify early molecular biomarkers of subclinical intestinal involvement in patients presenting with joint syndrome. Materials and methods . The study enrolled children diagnosed with juvenile idiopathic arthritis, juvenile psoriatic arthritis, and Crohn’s disease, alongside healthy controls. The concentrations of serum cytokines were quantified using enzyme-linked immunosorbent assay. Data were evaluated using Tukeyʼs post-hoc test, principal component analysis, and heatmapping. Results . Initial analysis revealed shared immunopathogenetic pathways across the examined cohorts. However, subsequent stratification of patients with juvenile idiopathic arthritis into clinical variants uncovered an atypical phenomenon: patients with the enthesitis form exhibited a profound, isolated elevation in the levels of proinflammatory cytokines IL-18, IL-27, and IL-31, as well as the anti-inflammatory cytokine IL-1ζ. Prospective follow-up demonstrated that comorbid Crohn's disease subsequently manifested in 80% of the patients within this specific subgroup. Multivariate statistical analysis enabled distinct visualization and spatial segregation of these patients into an independent cluster specific to the coexisting pathology. Conclusions. The identified phenomenon of concurrent upregulation of IL-18, IL-27, IL-31, and IL-1ζ in children with joint syndrome is pathogenetically driven by the gut–joint axis. This specific cytokine panel, combined with multivariate statistical modeling, can serve as a molecular fingerprint for the early screening of subclinical intestinal inflammation. This approach facilitates the timely diagnosis of latent Crohn's disease prior to the development of severe systemic complications.

  • The significance of ultrasound examination in arthropathies in patients with inflammatory bowel disease: focus on paediatric practice

    by A.V. Polyanskaya, S.N. Chebysheva, N.V. Aleksakova, A.V. Zhelannikova, K.G. Abramova, A.D. Pilkh, O.G. Shirinskaya, E.YU. Litvinova, E.A. Brileva

    Background. Inflammatory bowel disease is a chronic immune-inflammatory disease with intestinal and extraintestinal manifestations. Among the extraintestinal manifestations of inflammatory bowel disease, one of the most common is musculoskeletal involvement, which proceeds in the form of seronegative spondyloarthropathies. The involvement of joints in the pathological process affects the functional state and quality of life of the child and requires changes in the scope of therapeutic measures, therefore early diagnosis of the condition of joints and ligaments is of great importance. The non-specific nature of the symptoms and the high frequency of subclinical inflammation in the joints in inflammatory bowel disease make ultrasound examination particularly important as a method of early and safe visualisation of inflammatory changes. Objective. The aim of the study was to analyse the nature of ultrasonic changes in the joints of children with arthropathies associated with Crohn's disease. Materials and methods. The study included 28 children with Crohn's disease and inflammatory bowel disease in the form of joint damage, with a mean age of 11.77 ± 1.45 (95% confidence interval [10.12; 13.12]) years. The diagnosis of Crohn's disease was established in accordance with the Clinical Guidelines for Crohn's disease in Paediatric Patients, 2024. A clinical analysis of joint involvement options was performed; enthesitis was assessed using the MASES index. Arthrosonography was performed on 154 joints of various locations. The study was conducted using a Voluson E8 expert-class ultrasound machine with a linear transducer with a frequency of 6-15 MHz. Ultrasound signs of joint damage were assessed according to the following characteristics: reduction in hyaline cartilage thickness, effusion in the joint capsules (homogeneous/heterogeneous), thickening of the synovial membrane. Quantitative indicators are presented as M ± SD (mean ± standard deviation) with 95% confidence intervals. Qualitative variables are described using absolute and relative (%) frequencies. Student's t-distribution was used to calculate the confidence intervals of the mean values. Results. In our group of 28 children with Crohn's disease, boys predominated – 18/28 (64.3%), while girls accounted for 10/28 (35.7%). The average age of onset was 8.46 ± 1.33 (95% confidence interval [7.13; 9.79]) years. Joint syndrome in 6/28 (21.4%) children was represented by spondyloarthritis, in 14/28 (50%) by oligoarthritis, and in 8/28 (28.6%) by polyarthritis. Physical examination of 28 children revealed changes in 67 joints in the form of effusion/proliferative component. Enthesopathic syndrome was present in 12/28 (42.9%) children, with a mean MASES index of 2.21 ± 2.81 (95% confidence interval [1.12; 3.30]). Arthrosonography was performed on 154 joints of various locations. The most common joint change on ultrasound was synovitis (116/154, 75.3%), with minimal synovitis in 75/116 (64.7%) cases and significant synovitis in 37/116 (31.9%) cases. Diffuse thickening of the synovial membrane was detected in 116 joints (116/154, 75.3%). Only in 2/154 (1.3%) joints was there thinning and unevenness of the cartilage contour. Tenosynovitis was detected in 8/154 (5.2%) cases, and Achilles bursitis in 2/154 (1.3%) cases. Conclusion. In our study, the clinically detectable number of affected joints was 67, while arthrosonography revealed pathological changes in 154 joints, in most patients (65%) mainly in the form of minimal synovitis. Thus, subclinical joint inflammation in children with inflammatory bowel disease occurs much more frequently than is determined by physical examination of patients. The introduction of ultrasound as a screening tool, as well as in the complex dynamic observation of children with inflammatory bowel disease, can contribute to the early detection of inflammatory changes in the joints and the timely optimisation of treatment tactics.

  • Open Access

    Inflammatory bowel disease in children associated with juvenile psoriatic arthritis: features of joint syndrome

    by A.V. Polyanskaya, S.N. Chebysheva, E.A. Yablokova, I.M. Korsunskaya, E.S. Zholobova, М. Н. Николаева, Y.O. Kostina, Е. В. Борисова, E.YU. Polotnyanko, В. С. Крикун, et al.

    Background. Inflammatory bowel diseases, which include Crohn's disease and ulcerative colitis, are immune-mediated inflammatory diseases with a complex pathogenesis. In addition to the involvement of the intestinal wall in the pathological process, systemic extraintestinal manifestations are observed in Crohn's disease and ulcerative colitis, and there is also often an association with psoriasis and psoriatic arthritis. Objective. Purpose of the study was to analyze the nature of the articular syndrome in children with inflammatory bowel diseases associated with juvenile psoriatic arthritis. Materials and methods. A retrospective analysis of the nature of the articular syndrome was carried out in a group of children with inflammatory bowel diseases associated with juvenile psoriatic arthritis (20 patients, mean age 12.7 years (95% CI [11.01; 14.29]). The diagnosis of juvenile psoriatic arthritis was established according to the Vancouver diagnostic criteria (1989). The diagnosis of Crohn's disease was established in accordance with Clinical recommendations for Crohn's disease for pediatric patients, 2025. The diagnosis of ulcerative colitis was established in accordance with Clinical guidelines for ulcerative colitis for pediatric patients, 2025. Statistical processing was performed using parametric methods and exact formulas for percentages. Results. 17/20 (85%) of our patients were diagnosed with Crohn's disease, inflammatory form, 3/20 patients (15%) – ulcerative colitis. The diagnosis of definite juvenile psoriatic arthritis, according to the Vancouver diagnostic criteria, was made in 11/20 patients (55%), probable – in 9/20 (45%). Boys predominated in the group – 14/20 (70%). The mean disease duration was 5.0 years (95% CI [3.21, 6.79] years). 13/20 (65%) patients had relatives 1 and 2 degrees of relatives suffered from psoriasis. All children with definite psoriatic arthritis (11/20 children) had plaque (vulgar) psoriasis. In 15/20 (75%) patients, the onset of articular syndrome was asymmetrical oligoarthritis. At the height of the disease, the oligoarticular variant was observed in 10/20 (50%) children, rheumatoid-like (polyarticular) in 3/20 (15%), spondyloarthritis with damage to peripheral joints in 7/20 (35%). The most commonly affected joints were the knee (15/20 (75%)), ankle (5/20 (25%)), and hip (8/20 (40%)) joints. Conclusions. The articular syndrome in inflammatory bowel diseases associated with juvenile psoriatic arthritis is characterized by a frequent onset of the disease with joint damage (in 40%), asymmetric oligoarthritis at the onset and at the height of the disease, while isolated juvenile psoriatic arthritis is characterized by a pattern of development of the articular syndrome from oligo- to polyarthritis. The association of inflammatory bowel diseases and juvenile psoriatic arthritis is characterized by a high percentage of spondyloarthritis with damage to peripheral joints (35%). The most common joints involved are the knee and hip joints (75% and 40%), with a high incidence of enthesitis (55%), while in isolated juvenile psoriatic arthritis the knee and ankle joints are most often affected. The course of inflammatory bowel diseases against the background of psoriatic arthritis requires an individual approach to patient management and selection of therapy aimed at the common links in the pathogenesis of these conditions.


  • Open Access

    Towards the differential diagnosis of joint syndrome: Juvenile idiopathic arthritis and joint lesions in inflammatory bowel disease

    by A. V. Polyanskaya, S. N. Chebysheva, I. M. Korsunskaya, N. A. Geppe, M. N. Nikolaeva, E. Yu. Afonina, V. A. Seraya, Yu. O. Kostina, E. V. Borisova, E. S. Zholobova, et al.

    Introduction. A range of diseases that require differential diagnostic search in persistent joint syndrome in children include juvenile idiopathic arthritis (JIA) and joint lesions in inflammatory bowel diseases (IBD). Aim . To analyze and compare the nature of joint syndrome in children with JIA and Crohn’s disease (CD) with joint lesions. Materials and methods . The joint syndrome was analyzed in a group that included 23 children with JIA and 24 children with Crohn’s disease with joint lesions. Statistical data were processed using parametric tests and exact formulas for percentage-based relationships. Results . JIA typically affected the knee, ankle, hip, and wrist joints (21 (91.3%), 14 (60.9%), 15 (65.2%), and 5 (21.7%) children, respectively). Enthesopathies were detected in 4 (17.4%) children. CD caused spondyloarthritis in 5 children (10.8%) and peripheral joint lesions in 15 patients (58.3%). Knees, hips, and small joints of the hands and feet were affected most frequently (14 (58.3%), 13 (54.2%), 9 (37.5%), and 4 (16.7%) children, respectively). Enthesopathies were detected in 10 children (41.7%). An analysis of the comparative frequency of joint lesions in JIA and CD showed that the knee, ankle, and wrist joints were significantly more often involved in JIA, while enthesitis were significantly more often detected in CD (p < 0.05). 5 patients (10.8%) had CD-associated spondyloarthritis. Antinuclear antibodies were identified significantly more often in patients with JIA (p < 0.05). The article is also illustrated with two clinical case reports. Conclusions . The data presented demonstrate differences in the nature of joint syndrome in children with JIA and CD. A detailed history taking, physical examination, and assessment of the nature of the joint syndrome make it possible to establish a correct diagnosis and select a rational approach to the management of patients.


  • Joint damage in children with inflammatory bowel diseases – experience of one center

    by A. V. Polyanskaya, S. N. Chebysheva, E. A. Yablokova, I. M. Korsunskaya, N. A. Geppe, E. V. Borisova, E. Y. Polotnyanko, V. S. Krikun, S. B. Krutikhina, M. B. Aksenova, et al.

    Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, are systemic immunoinflammatory diseases. Among the extraintestinal manifestations of these diseases, musculoskeletal lesions with seronegative spondyloarthropathies are the most common.The aim of the study was to evaluate the frequency and nature of joint lesions in patients with inflammatory bowel diseases observed at the Sechenov Centre for Maternity and Childhood in the period from 2017 to 2024.Materials and Methods. The diagnoses of Crohn’s disease and ulcerative colitis were established in accordance with the clinical recommendations of the Union of Paediatricians of Russia. The classification criteria of the International Working Group on Ankylosing Spondylitis, 2011 and the Diagnostic Criteria for Juvenile Spondyloarthritis according to Garmisch–Partenkirchen, 1987 were used to verify the nature of joint damage. The prevalence of joint damage variants in the general group of children with inflammatory diseases of the intestine was analysed, as well as separately in groups with Crohn’s disease and ulcerative colitis.Results. Of 175 children with inflammatory bowel disease, 77 (44%) had extraintestinal manifestations in the form of joint syndrome: 52 (68%) of them with Crohn’s disease and 25 (32%) with ulcerative colitis. Isolated arthralgias were noted in 7 of 77 children (9.1%). Of the 77 children, peripheral arthropathy in the form of oligoarthritis of large joints was noted in 64 (83.1%) patients, including 40 (62.5%) with Crohn’s disease and 24 (37.5%) with ulcerative colitis. Spondyloarthritis occurred in 6 (7.8%) children, in 5 children with Crohn’s disease and in 1 child with ulcerative colitis. Joint syndrome preceded intestinal manifestations of the disease in 40 (52%) of 77 patients with spondyloarthropathy.Conclusions. The analysis of the prevalence of spondyloarthropathies in inflammatory bowel diseases in children showed its high frequency — 44%, significantly more often in Crohn’s disease. Among the patients with arthropathy associated with inflammatory bowel disease, the joint syndrome preceded the intestinal syndrome in 52% of cases. Peripheral oligoarthritis prevailed in 83.1% of our patients. Spondyloarthritis was detected in 7.8% of children, the vast majority of them with Crohn’s disease.


  • The relationship of the variant of joint syndrome with provoking factors in the onset of juvenile psoriatic arthritis

    by S. N. Chebysheva, N. A. Geppe, I. M. Korsunskaya, V. V. Sobolev, A. V. Polyanskaya, L. G. Khachatryan, M. N. Nikolaeva, E. Yu. Afonina, I. M. Farber, Ya. G. Ambarcumova

    Juvenile psoriatic arthritis is a chronic inflammatory disease of the peripheral joints, spinal joints and entheses, which occurs in 10–25% of patients with psoriasis. Studying the features of the juvenile psoriatic arthritis’s debut will increase early diagnosis and will help to avoid disability, socialize and integrate the child into society.Objective. The purpose of the work is to identify the relationship between the variant of the articular syndrome of juvenile psoriatic arthritis at the onset of the disease and the provoking factor of the disease.Material and methods. 155 patients with an established diagnosis of juvenile psoriatic arthritis were examined. To analyze the data, universal nonparametric (randomization-permutation) algorithms for constructing confidence intervals (CI) were used. Comparison of groups by binary and categorical features is performed using the exact Fisher criterion for tables 2×2 or the exact Fisher–Freeman– Holton criterion for tables r×c. The reliability was assessed (p<0.05) and by the nonparametric Mann–Whitney method (p<0.05).Results. The relationship with the variant of the onset of articular syndrome with the provoking factor of the disease was revealed: in the rheumatoid-like variant, the proportion of patients with stress (p<0.005) acting as a trigger is higher; in spondyloarthritis, the proportion of the infectious factor is higher (p<0.005).Conclusion. The relationship with the variant of the onset of articular syndrome with the provoking factor of the disease was revealed. Stress was the leading provoking factor in our patients, and the infectious factor was the second most common.

  • Open Access

    Challenges in the diagnosis of inflammatory bowel diseases in children: Author's data and a clinical case

    by Angelina V. Polyanskaya, Svetlana N. Chebysheva, Ekaterina A. Yablokova, Irina M. Korsunskaya, Natalia A. Geppe, Elena V. Borisova, Elena Yu. Afonina, Valentina A. Seraya, Maria N. Nikolaeva, Yulia O. Kostina, et al.

    Inflammatory bowel diseases (IBD) Crohn's disease (CD) and ulcerative colitis (UC) are a group of idiopathic abnormal bowel conditions with unclear etiology and similar clinical courses. In addition to intestinal syndrome, these diseases are often associated with extraintestinal manifestations, the most common of which is the involvement of the peripheral joints and axial skeleton. The increase in the incidence of IBD, especially CD, in childhood warrants further study of this condition's features, including the most common extraintestinal manifestation: joint involvement (JI) in pediatric patients with IBD. Aim. To analyze the features of JI in CD and UC and the timing of its occurrence associated with IBD onset. Materials and methods. We reviewed 146 case histories of patients aged 4 to 18 diagnosed with CD and UC treated in the Gastroenterological Department and Rheumatological Department No.1 of the Mother and Child Center of Sechenov University from 2017 to 2024. The diagnosis of CD and UC was established following the clinical guidelines of the Union of Pediatricians of Russia for diagnosing and treating CD (2021) and UC (2024) in children. A rheumatologist examined the joints and assessed the JI. The classification criteria of the Assessment of SpondyloArthritis International Society (ASAS, 2011) for predominantly peripheral spondyloarthritis and the Garmisch-Partenkirchen JAS Diagnostic Criteria (1987) were used to verify the cause of the joint involvement. Mean values and standard deviation (M±σ) were used to summarize and estimate demographic continuous variables. Absolute values and percentages were calculated for patients in each study group. Results. Of the 146 patients, 60 (41%) had a combination of JI and IBD. Sixty children aged 4 to 18 with IBD and JI were divided into three groups: 36 (60%) patients with CD, 19 (32%) with UC, and 5 (8%) children with undifferentiated colitis (UndC). The mean age of patients with CD was 14.06±0.5, with UC–13.6±0.3, and UndC–15.2±0.2 years. Among all 60 patients, JI manifested with peripheral arthritis (PA) in 25 (42%) subjects, spondyloarthritis (SpA) in 16 (27%) subjects, or only arthralgias without evident inflammatory changes in the joints in 19 (31%). The analysis of JI variants by groups in children with CD (n=36) showed PA in 15 (42%), SpA in 12 (33%), and isolated arthralgia in 9 (25%) patients. The prevalence of PA and arthralgia among boys and girls with CD was comparable (60 and 40% of PA, 56 and 44% of arthralgias, respectively); the prevalence of SpA in boys with CD was significantly higher: found in 11 (92%) boys. In the group of children with UC (n=19), a high prevalence of PA and isolated arthralgia was reported: 8 (42%) and 9 (47%) patients, respectively. SpA was diagnosed in 2 (11%) children with UC. Of the 60 children with JI and IBD, 30 (50%) developed the disease with joint involvement. CD onset was associated with JI significantly more often than UC onset: of 30 children with JI, 21 (70%) were first diagnosed with rheumatic joint disease, and then CD was detected during follow-up. The disease first manifested with joint involvement in 6 (20%) patients with UC and 3 (10%) with UndC. The time interval from the onset of JI to the onset of the intestinal syndrome (and/or IBD diagnosis) varied widely from 1 month to several years; in 1 patient, it was more than 8 years. In 8 (27%) patients, this time interval was 1 to 3 months; in 6 (20%) patients, the symptoms of the underlying disease appeared within 12 to 24 months from the joint involvement manifestation. The atypical onset and course of the disease make diagnosis challenging and require increased doctor attention to patient management. As an illustration, the article presents a clinical case of an atypical onset and course of CD associated with juvenile SpA.


  • Efficacy and safety of secukinumab (Cosentyx) in patients with juvenile psoriatic arthritis

    by S. N. Chebysheva, E. S. Zholobova, N. A. Geppe, I. M. Korsunskaya, A. V. Polyanskaya, M. N. Nikolaeva, E. Yu. Afonina, Yu. O. Kostina, V. A. Seraya, K. V. Aleksanyan

    Psoriatic arthritis is a chronic inflammatory disease of the peripheral joints, spinal joints and entheses, occurring in 10–25% of patients with psoriasis. Juvenile psoriatic arthritis is classified as a subtype of juvenile idiopathic arthritis. Treatment of juvenile psoriatic arthritis is challenging. One of the main difficulties is that the drugs used in adult patients have restrictions for use in pediatric practice, which limits the available therapeutic options. There are few studies assessing the effectiveness and safety of secakinumab therapy in pediatric practice.Objective. To evaluate the effectiveness and safety of secukinumab (Cosentyx) therapy in children with juvenile psoriatic arthritis in real clinical practice.Methods. The effectiveness of therapy was assessed using the “pediatric” criteria of the American College of Rheumatology (ACRpedi) after 6, 12 and 18 months from the date of administration of secuquinumab (Cosentyx) therapy in 8 patients with jPsA. The main criterion for treatment effectiveness was the achievement of at least 50% (ACR pedi 50) improvement. To assess the area and severity of skin manifestations of psoriasis, the PASI (Psoriasis Area Severity Index) index was used. To assess the area of skin affected by psoriatic rashes, the body surface area index (BSA) was used.Results. By the 6th month of therapy with secukinumab (Cosentyx), a general assessment of the effectiveness of treatment was completed in all children (n-8): ACRpedi50 in 1 (12.5%), ACRpedi70 in 3 (37.5%); ACRpedi90/100 in 4 (50%). By the 12th month of therapy with secukinumab (Cosentyx), according to a comprehensive assessment of the effectiveness of therapy, all remaining children (n-5) responded to treatment: ACRpedi70/90/100 were 60/60/60%. Inactive disease status was achieved in 60% of cases. By the 18th month from the start of therapy, ACRpedi was assessed in 5 children: ACRpedi 70/90/100 were 60/60/60%, respectively. In 3 patients from the initial number of children, pharmacological clinical and laboratory remission of the disease was achieved by the 18th month of therapy.

  • Features of the onset of juvenile psoriatic arthritis

    by S. N. Chebysheva, N. A. Geppe, I. M. Korsunskaya, V. V. Sobolev, A. V. Polyanskaya, L. G. Khachatryan, M. N. Nikolaeva, E. Yu. Afonina

    Juvenile psoriatic arthritis is a chronic inflammatory disease of the peripheral joints, spinal joints and entheses, which occurs in 10–25% of patients with psoriasis. Studying the features of the juvenile psoriatic arthritis debut will increase early diagnosis and will help to avoid disability, socialize and integrate the child into society.Purpose. To identify the relationship between the onset of juvenile psoriatic arthritis and the age and gender of the child, to trace the nature of the articular syndrome in our patients from the onset to the height of the disease.Methods. 155 patients with an established diagnosis of juvenile psoriatic arthritis were examined. To analyze the data, universal nonparametric (randomization-permutation) algorithms for constructing confidence intervals (CI) and statistical comparisons based on the bootstrap and Monte Carlo methods were used.Results. It was possible to identify a relationship between the onset variant and the gender of the child. The incidence of asymmetric oligoarthritis in boys and girls at onset was approximately the same, 68% and 59%, respectively, and did not differ significantly. At onset, girls had a higher incidence of rheumatoid-like arthritis (37%) (p<0.005), and boys had a higher incidence of spondyloarthritis (26%) (p<0.005). A relationship was also revealed between the onset, gender and age of the child. Girls aged 0–6 years most often debuted with asymmetric oligoarthritis (90%) (p<0.005), and at the age of 11–15 years — with the rheumatoid-like (polyarticular) variant (73%) (p<0.005). In boys aged 0–6 and 7–10 years, asymmetric oligoarthritis predominated (100% and 100%, respectively) (p <0.005), and at the age of 11–15 years, spondyloarthritis with damage to peripheral joints was more common (73%) (p<0.005). A transformation of the articular syndrome was revealed: if at the onset of the disease asymmetric oligoarthritis was most common (63%), then 5 years from the onset of the disease, 40.7% of the observed children had a rheumatoid-like (polyarticular) variant of the disease.Conclusion. The course of juvenile psoriatic arthritis may be influenced by the gender and age of the child at onset; a certain pattern of the course of juvenile psoriatic arthritis from oligoarthritis to the polyarticular (rheumatoid-like) variant has been identified.